跳至主要内容
临床试验/NL-OMON34405
NL-OMON34405已完成不适用

The effect of vinegar co-ingestion on postprandial glucose control in type 2 diabetes patients. - Vinegar co-ingestion in type 2 diabetes.

Maastricht University0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Male type 2 diabetes patients:
  • -40-70 yrs.
  • -BMI 25-35 kg/m2
  • -oral blood glucose lowering medication;Male control subjects:
  • -40-70 jr.
  • -BMI 25-35 kg/m2

排除标准

  • Exogenous insulin therapy; HbA1c <6.5% or >10.0%; diagnosed impaired renal or liver function; morbid obesity (BMI>35 kg/m2); incident cardiovascular events in the last year (heart attack, stroke, aneurysms). Furthermore, subjects with an ulcus pepticum, ulcus duodeni, ulcus ventriculi and/or oesophagal reflux will be excluded. In addition, subjects using antacids, H-2-receptor blockers, proton pump inhibitors, NSAID*s, and/or prokinetic agents will be excluded.

研究者

相似试验